Λογότυπο www.galinos.gr Beta
 

Ιατροφαρμακευτική πληροφόρηση για τον επαγγελματία υγείας

Φάρμακα Δραστικές ουσίες Συμπληρώματα διατροφής Έλεγχος συγχορήγησης Νόσοι ICD-10
Κλαύδιος Γαληνός
Είσοδος χρηστών
Όνομα χρήστη
Συνθηματικό
Εικονίδιο Είσοδος χρήστη
Εικονίδιο Δωρεάν εγγραφή
Εικονίδιο Ανανέωση συνθηματικού

Ακολουθήστε μας Λογότυπο Facebook Λογότυπο Twitter

Αναζήτηση σε 63811 καταχωρήσεις
Εικονίδιο αναζήτησης

Βιβλιογραφική αναφορά

Προτάσεις

SPC, UK: Zithromax Capsules, Suspension (2012)

Εκδότης

Εκδότης Pfizer Limited
Διεύθυνση Ramsgate Road, Sandwich, Kent, CT13 9NJ
Σφάλμα Για την προβολή της πλήρους καταχώρησης χρειάζεται να έχετε συνδρομή σε ισχύ (αγορά συνδρομής).
Ολοκληρώνοντας τη διαδικασία δωρεάν εγγραφής θα αποκτήσετε, χωρίς καμία δέσμευση εκ μέρους σας, συνδρομή διάρκειας 30 ημερών.

Περιεχόμενα

Name of the medicinal product

ZITHROMAX CAPSULES. ZITHROMAX SUSPENSION.

Qualitative and quantitative composition

Active ingredient: azithromycin. Zithromax Capsules contain azithromycin dihydrate 262.05 mg equivalent ...

Pharmaceutical form

Zithromax Capsules are white, hard gelatin capsules marked Pfizer and ZTM 250. Zithromax Powder for Oral ...

Therapeutic indications

Azithromycin is indicated for the treatment of the following infections when known or likely to be due ...

Posology and method of administration

Method of administration Zithromax should be given as a single daily dose. In common with many other ...

Contraindications

Zithromax is contra-indicated in patients with a known hypersensitivity to azithromycin or any macrolide ...

Special warnings and precautions for use

As with erythromycin and other macrolides, rare serious allergic reactions including angioneurotic oedema ...

Interaction with other medicinal products and other forms of interaction

Antacids: In a pharmacokinetic study investigating the effects of simultaneous administration of antacid ...

Pregnancy and lactation

Animal reproduction studies have been performed at doses up to moderately maternally toxic dose concentrations. ...

Effects on ability to drive and use machines

There is no evidence to suggest that Zithromax may have an effect on a patients ability to drive or operate ...

Undesirable effects

Zithromax is well tolerated with a low incidence of side effects. The section below lists the adverse ...

Overdose

Adverse events experienced in higher than recommended doses were similar to those seen at normal doses. ...

Pharmacodynamic properties

Pharmacotherapeutic group: Antibacterials for systemic use ATC code: J01FA10 Mode of action Zithromax ...

Pharmacokinetic properties

Absorption Bioavailability after oral administration is approximately 37%. Peak plasma concentrations ...

Preclinical safety data

Phospholipidosis (intracellular phospholipid accumulation) has been observed in several tissues (e.g. ...

List of excipients

Zithromax Capsules contain: Lactose, magnesium stearate, maize starch, and sodium lauryl sulphate. The ...

Incompatibilities

None known.

Ημερομηνία λήξης

Capsules Aluminium/PVC blister strips in carton boxes: 60 months Polythene capsule container with child ...

Special precautions for storage

None.

Nature and contents of container

Zithromax Capsules are available as: Packs of 2 capsules. Aluminium/PVC blister strips, 2 capsules per ...

Special precautions for disposal and other handling

When dispensing the 15 ml pack, advice should be given as to whether the dose should be measured using ...

Marketing authorization holder

Pfizer Limited Ramsgate Road Sandwich Kent CT13 9NJ United Kingdom

Marketing authorization number(s)

PL 00057/0335 PL 00057/0336

Date of first authorization / renewal of the authorization

4 April 1991 / 7 September 1996

Date of revision of the text

22 March 2012
Απαγορεύεται η αναπαραγωγή και αναδιανομή. Το έργο επεξεργασίας των παραπάνω πληροφοριών αποτελεί πνευματική ιδιοκτησία της Ergobyte Πληροφορική Α.Ε. και προστατεύεται από τη νομοθεσία περί πνευματικών δικαιωμάτων.